5344 related articles for article (PubMed ID: 3895683)
1. Immunohistochemical reactivity of the antimelanoma monoclonal antibody MEL-1.
Clemente C
Tumori; 1985 Jun; 71(3):225-32. PubMed ID: 3895683
[TBL] [Abstract][Full Text] [Related]
2. The differential reactivity of benign and malignant nevomelanocytic lesions with mouse monoclonal antibody TNKH1.
Nakanishi T; Hashimoto K
Cancer; 1987 Apr; 59(7):1340-4. PubMed ID: 3545436
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
Dell'Erba L; Calo-Gabrieli G; Caruso ML; Thomas R; Cortino G; Valentini AM; Muto P; Albrizio M; Pastena MI; Lastoria S
Anticancer Res; 2001; 21(2A):925-30. PubMed ID: 11396186
[TBL] [Abstract][Full Text] [Related]
5. Immunoperoxidase staining for Ia-like antigens in paraffin-embedded tissues from human melanoma and lung carcinoma.
Wilson BS; Herzig MA; Lloyd RV
Am J Pathol; 1984 Apr; 115(1):102-8. PubMed ID: 6369992
[TBL] [Abstract][Full Text] [Related]
6. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
7. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
Maeda K; Jimbow K
Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.
Saab J; Santos-Zabala ML; Loda M; Stack EC; Hollmann TJ
Am J Dermatopathol; 2018 Apr; 40(4):259-264. PubMed ID: 28654463
[TBL] [Abstract][Full Text] [Related]
9. Production and characterisation of an antimelanoma monoclonal antibody KBA.62 using a new melanoma cell line reactive on paraffin wax embedded sections.
Cohen-Knafo E; al Saati T; Aziza J; Ralfkiaer E; Selves J; Gorguet B; Delsol G
J Clin Pathol; 1995 Sep; 48(9):826-31. PubMed ID: 7490315
[TBL] [Abstract][Full Text] [Related]
10. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
Kornstein MJ; Brooks JS; Elder DE
Cancer Res; 1983 Jun; 43(6):2749-53. PubMed ID: 6342758
[TBL] [Abstract][Full Text] [Related]
11. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors.
Atkinson B; Ernst CS; Ghrist BF; Ross AH; Clark WH; Herlyn M; Herlyn D; Maul G; Steplewski Z; Koprowski H
Hybridoma; 1985; 4(3):243-55. PubMed ID: 4043988
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathology.
Thomson W; MacKie RM
J Am Acad Dermatol; 1989 Dec; 21(6):1280-4. PubMed ID: 2685063
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
17. Multiple assay characterization of murine monoclonal antimelanoma antibodies.
Stuhlmiller GM; Borowitz MJ; Croker BP; Seigler HF
Hybridoma; 1982; 1(4):447-60. PubMed ID: 6208139
[TBL] [Abstract][Full Text] [Related]
18. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
[TBL] [Abstract][Full Text] [Related]
19. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone KT; van Belle P; Elenitsas R; Elder DE
Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
[TBL] [Abstract][Full Text] [Related]
20. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
